Abstract：Objective To explore the diagnostic value of breast ultrasound DOT combined with serum CA15-3 and CEA detection in breast tumors. Mehtods From August 2012 to December 2015, in Sichuan Province People's Hospital, 136 female breast cancer patients were selected as group A, 120 female benign breast tumor patients were selected as group B, 120 female healthy physical examination were selected as group C, the MHC, serum CA15-3 and CEA levels in three groups were detected and analyzed. Results The levels of CA15-3 and CEA in group A were significantly higher than those in group B and group C, the differences were statistically significant (P < 0.05), CA15-3 and CEA levels in group B and group C were compared, the differences were not statistically significant (P > 0.05). Ultrasound, combined serum CA15-3, CEA detecting breast tumor positive rate was significantly higher than the respective single detecting, the differences were statistically significant (P < 0.05), ultrasound, combined serum CA15-3, CEA detecting breast cancer sensitivity rate was significantly higher than the respective single detecting, the differences were statistically significant (P < 0.05). ROC curve analysis of joint detection in the diagnosis of breast malignant tumor AUC was 0.886 (95%CI 0.689-0.993), the maximum diagnostic threshold was 135.0 μmol/L, the maximum value of Youden's index was 0.70, the specificity was 91.5%, sensitivity was 95.5%. Conclusion Breast ultrasound DOT combined with serum CA15-3, CEA detection can make up for the defect of single index examination, so as to improve the diagnosis rate of breast cancer, breast cancer has good auxiliary diagnostic value.
庹有林. 乳腺超声光散射成像联合血清CA15-3、CEA检测在乳腺肿瘤中的诊断价值[J]. 中国医药导报, 2017, 14(26): 90-93.
TUO Youlin. Diagnostic value of breast ultrasound DOT combined with serum CA15-3 and CEA detection in breast tumors. 中国医药导报, 2017, 14(26): 90-93.
[1] 中国乳腺癌内分泌治疗专家共识专家组.中国乳腺癌内分泌治疗专家共识（2015年版）[J].中国癌症杂志，2015， 25（9）：755-760.
[2] 陈万青，郑荣寿.中国女性乳腺癌发病死亡和生存状况[J].中国肿瘤临床，2015，42（13）：668-674.
[3] 牛司华，朱庆莉，姜玉新，等. 乳腺癌超声光散射断层成像与缺氧诱导因子-1α的相关性[J].中国医学科学院学报，2016，38（3）：341-345.
[4] 张新毅.乳腺钼靶X射线摄片联合血清CA15-3、CEA和OPN在乳腺癌诊断中的价值[J].中国老年学杂志，2014， 34（23）：6640-6641.
[5] Edge SB， Byrd DR， Compton CC， et al. AJCC cancer staging manual [M]. 7th ed.New York：Springer，2010：347-376.
[6] 全国肿瘤防治办公室与中国抗瘤协会.中国常见恶性肿瘤诊治规范[M].北京：北京医科大学和中国协和医科大学联合出版社，1990：24-25.
[7] Radiology ACO. ACR BI-RADS?誖-Atlas der Mammadiagnostik [M]. Berlin：Springer Berlin Heidelberg，2016.
[8] 左婷婷，陈万青.中国乳腺癌全人群生存率分析研究进展[J].中国肿瘤临床，2016，43（14）：639-642.
[9] 陈万青，郑荣寿.中国女性乳腺癌发病死亡和生存状况[J].中国肿瘤临床，2015，42（13）：668-674.
[10] 张慧，山长平.双侧原发性乳腺癌高危因素的研究进展[J].山东医药，2016，56（13）：99-101.
[11] Ban HY， Schweiger M， Kavuri VC， et al. Heterodyne frequency-domain multispectral diffuse optical tomography of breast cancer in the parallel-plane transmission geometry [J]. Med Phys，2016，43（7）：4383-4395.
[12] Wang HL， Zhang ZL. Analysis of the relationship between ultrasound of breast cancer DOT-SDI and the expression of MVD，VEGF and HIF-1α [J]. Cell Biochem Biophys，2014，70（1）：205-208.
[13] 王建宇.乳腺癌术后诊断及治疗中肿瘤标志物联合检测的临床价值[J].中国妇幼保健，2014，29（31）：5167-5169.
[14] Dai DN， Chen B， Tang HL，et al. Nomograms for predicting the prognostic value of pre-therapeutic CA15-3 and CEA serum levels in TNBC patients [J]. PLoS One，2016， 11（8）：e0161902.
[15] Fu YJ， Li H. Assessing clinical significance of serum CA15-3 and carcinoembryonic antigen （CEA） levels in breast cancer patients： a meta-analysis [J]. Med Sci Monitor，2016，6（22）：3154–3162.
[16] Le Rhun E， Kramar A， Salingue S， et al. CSF CA 15-3 in breast cancer-related leptomeningeal metastases [J]. J Neuro Oncol，2014，117（1）：117-124.
[17] 陈艳，欧阳新平，何平平.超声联合CA15-3和CEA检测在乳腺癌诊断中的临床意义[J].中国现代医学杂志，2014，24（23）：63-66.
[18] 叶云，钟英英，孙宇飞，等.乳腺癌外周血中分子检测标记的筛选[J].肿瘤防治研究，2015，42（7）：657-661.
[19] 蒋显勇，易艳军，梁庄严，等.血清HER-2/neu、TPS、CA15-3和TSGF联合检测在乳腺癌诊断中的价值[J].实用医学杂志，2016，32（24）：4115-4117.
[20] 周成香，魏倩，朱小虎，等.超声造影联合弹性成像技术在乳腺癌诊断中的价值[J].中国医学装备，2016，13（11）：64-66.
[21] 朱娟娟，胡志军，沈国栋，等.HER2 ECD和CA15-3联合检测对乳腺癌复发转移的诊断价值[J].安徽医科大学学报，2016，51（9）：1378-1381.
2017, Vol. 14 
京公网安备 11010502046598号